Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for PLA2 UND HMG-COA-INHIBITOREN ZUR BEHANDLUNG VON PATHOLOGISCHEN ZUSTÄNDEN, DIE HÄMOLYSE, ZEREBRALES ÖDEM UND AKUTE NIERENSCHÄDIGUNG VERURSACHEN
Details for 2017790643
Up to date per 10.06.2026
Actions
Details for 2017790643
Title / Product Name
PLA2 UND HMG-COA-INHIBITOREN ZUR BEHANDLUNG VON PATHOLOGISCHEN ZUSTÄNDEN, DIE HÄMOLYSE, ZEREBRALES ÖDEM UND AKUTE NIERENSCHÄDIGUNG VERURSACHEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2017790643
EP Publication Number
3448378
E-Number
1676585
Language
EN
PCT Number
US17030436
Publication Date
06.03.2019 A
17.04.2024 B1
Registration Date
17.04.2024
AT Publication Date
15.05.2024
Application Date
01.05.2017
Registration Number
-
Priorities
29.04.2016
US
201662329611 P
23.05.2016
US
201662340075 P
17.11.2016
US
201662423693 P
IPC
A61K 31/404 20060101AFI20200304BHEP
Maximum Duration of Protection
01.05.2037
Owner
Ophirex, Inc.5643 Paradise Drive No. 2 Corte Madera, CA 94925US
Representative
No representatives present
Inventor
LEWIN, Matthew R.c/o Ophirex Inc. 5643 Paradise Drive 2 Corte Madera California 94925US